Key result
LDL-C levels show no significant association with incident ASCVD in adults aged 75 and older.
Cohort (n=2,667)
Yes
Answers are grounded in this paper and cite their sources.
Prospective cohort study shows no association between LDL cholesterol and cardiovascular disease in adults aged 75 and older, questioning the predictive value of LDL in late life.
BACKGROUND/OBJECTIVES: Elevated low-density lipoprotein cholesterol (LDL-C) in early adulthood is associated with increased risk of atherosclerotic cardiovascular disease (ASCVD). The strength of the association between LDL-C and ASCVD among older adults, however, is less understood. DESIGN: We examined individual-level cohort data from the National Institutes of Health Pooled Cohorts (Framingham Study, Framingham Offspring Study, Multi-Ethnic Study of Atherosclerosis, and Cardiovascular Health Study), which prospectively measured CVD risk factors and incident disease. SETTING: Prospective cohort study. PARTICIPANTS: Adults, aged 75 years or older, free of ASCVD. MEASUREMENTS: We evaluated the associations between LDL-C and incident ASCVD (stroke, myocardial infarction, and cardiovascular death) in unadjusted analysis and in multivariable-adjusted Cox proportional hazards models. We assessed 5-year Kaplan-Meier ASCVD event rates in patients with and without hyperlipidemia (LDL-C ≥130 mg/dL or on lipid-lowering medications), stratified by the number of other risk factors, including smoking, diabetes, and hypertension. RESULTS: We included 2667 adults, aged 75 years or older (59% female), free of ASCVD; median age was 78 years, with median LDL-C of 117 mg/dL. In both unadjusted and adjusted analyses, there was no association between LDL-C and ASCVD (adjusted hazard ratio = 1.022; 95% confidence interval = 0.998-1.046; P = .07). Among adults without other risk factors (free of smoking, diabetes, and hypertension), event rates were similar between those with and without hyperlipidemia (Kaplan-Meier rates = 5.8% and 7.0%, respectively). Among adults with one or two or more other risk factors, the presence of hyperlipidemia was also not associated with 5-year CVD event rates (Kaplan-Meier rates = 12.8% vs 15.0% [P = .44] for one other risk factor and 21.9% vs 24.0% [P = .59] for two or more other risk factors). CONCLUSION: Among a well-characterized cohort, LDL-C was not associated with CVD risk among adults aged 75 years or older, even in the presence of other risk factors. J Am Geriatr Soc 67:2560-2567, 2019.
No takes yet. Share an insight, caveat, or question.
Nanna et al. (2019) conducted a cohort in Atherosclerotic cardiovascular disease (ASCVD) (n=2,667). Low-density lipoprotein cholesterol (LDL-C) / Hyperlipidemia (LDL-C ≥130 mg/dL or on lipid-lowering medications) vs. Lower LDL-C / No hyperlipidemia was evaluated on Incident atherosclerotic cardiovascular disease (stroke, myocardial infarction, and cardiovascular death) (HR 1.022, 95% CI 0.998-1.046, p=0.07). Low-density lipoprotein cholesterol levels were not associated with incident ASCVD in adults aged ≥75 years free of baseline CVD.
Synapse has enriched 10 related papers. Consider them for comparative context: